{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:31:08Z","timestamp":1790087468387,"version":"4.0.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-024-04341-w","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T05:29:13Z","timestamp":1735277353000},"page":"1451-1463","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinicopathological features and treatment outcomes of urothelial carcinoma variant histologies and non-urothelial bladder cancers"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4706-0495","authenticated-orcid":false,"given":"\u0130smet","family":"Seven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selin","family":"Akt\u00fcrk Esen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serhat","family":"Sekmek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130rfan","family":"Karahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00fcge","family":"B\u00fcy\u00fckaksoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuba Dilay","family":"K\u00f6kenek \u00dcnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do\u011fan","family":"Uncu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"issue":"5","key":"4341_CR1","doi-asserted-by":"publisher","first-page":"692","DOI":"10.21037\/tau.2016.06.13","volume":"5","author":"Y Klaile","year":"2016","unstructured":"Klaile Y et al (2016) Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease? Transl Androl Urol 5(5):692\u2013701","journal-title":"Transl Androl Urol"},{"issue":"6","key":"4341_CR2","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S0302-2838(03)00416-0","volume":"44","author":"P Dahm","year":"2003","unstructured":"Dahm P, Gschwend JE (2003) Malignant non-urothelial neoplasms of the urinary bladder: a review. Eur Urol 44(6):672\u2013681","journal-title":"Eur Urol"},{"issue":"1","key":"4341_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.urolonc.2007.07.010","volume":"27","author":"PC Black","year":"2009","unstructured":"Black PC, Brown GA, Dinney CP (2009) The impact of variant histology on the outcome of bladder cancer treated with curative intent. Urol Oncol 27(1):3\u20137","journal-title":"Urol Oncol"},{"issue":"4","key":"4341_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.euf.2019.09.003","volume":"6","author":"N Lobo","year":"2020","unstructured":"Lobo N et al (2020) What is the significance of variant histology in urothelial carcinoma? Eur Urol Focus 6(4):653\u2013663","journal-title":"Eur Urol Focus"},{"issue":"1","key":"4341_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/JU.0000000000001325","volume":"205","author":"A Hajiran","year":"2021","unstructured":"Hajiran A et al (2021) Pathological and survival outcomes associated with variant histology bladder cancers managed by cystectomy with or without neoadjuvant chemotherapy. J Urol 205(1):100\u2013108","journal-title":"J Urol"},{"issue":"1","key":"4341_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00345-018-2421-5","volume":"37","author":"S Alanee","year":"2019","unstructured":"Alanee S et al (2019) Update of the international consultation on urological diseases on bladder cancer 2018: non-urothelial cancers of the urinary bladder. World J Urol 37(1):107\u2013114","journal-title":"World J Urol"},{"issue":"4\u20136","key":"4341_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0940-2993(98)80015-8","volume":"50","author":"E Kunze","year":"1998","unstructured":"Kunze E (1998) Histogenesis of nonurothelial carcinomas in the human and rat urinary bladder. Exp Toxicol Pathol 50(4\u20136):341\u2013355","journal-title":"Exp Toxicol Pathol"},{"key":"4341_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.671969","volume":"11","author":"N Epaillard","year":"2021","unstructured":"Epaillard N et al (2021) Treatments outcomes in histological variants and non-urothelial bladder cancer: results of a multicenter retrospective study. Front Oncol 11:671969","journal-title":"Front Oncol"},{"issue":"6","key":"4341_CR9","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1097\/JU.0000000000001305","volume":"204","author":"K Mori","year":"2020","unstructured":"Mori K et al (2020) A systematic review and meta-analysis of variant histology in urothelial carcinoma of the bladder treated with radical cystectomy. J Urol 204(6):1129\u20131140","journal-title":"J Urol"},{"issue":"5","key":"4341_CR10","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.eururo.2016.04.037","volume":"70","author":"A Collazo-Lorduy","year":"2016","unstructured":"Collazo-Lorduy A et al (2016) Urachal carcinoma shares genomic alterations with colorectal carcinoma and may respond to epidermal growth factor inhibition. Eur Urol 70(5):771\u2013775","journal-title":"Eur Urol"},{"key":"4341_CR11","doi-asserted-by":"publisher","DOI":"10.14694\/EdBook_AM.2014.34.71","author":"J Abrams","year":"2014","unstructured":"Abrams J et al (2014) National Cancer Institute\u2019s Precision Medicine Initiatives for the new National Clinical Trials Network. Am Soc Clin Oncol Educ Book. https:\/\/doi.org\/10.14694\/EdBook_AM.2014.34.71","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"3","key":"4341_CR12","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.eururo.2023.04.030","volume":"84","author":"V Tateo","year":"2023","unstructured":"Tateo V et al (2023) Re: WHO Classification of Tumours, 5th Edition, Volume 8: Urinary and Male Genital Tumours. Eur Urol 84(3):348\u2013349","journal-title":"Eur Urol"},{"key":"4341_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2022.100661","volume":"33","author":"EM Yu","year":"2022","unstructured":"Yu EM et al (2022) Non-urothelial and urothelial variants of bladder cancer. Cancer Treat Res Commun 33:100661","journal-title":"Cancer Treat Res Commun"},{"issue":"4","key":"4341_CR14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s004280100479","volume":"439","author":"B Helpap","year":"2001","unstructured":"Helpap B (2001) Nonepithelial neoplasms of the urinary bladder. Virchows Arch 439(4):497\u2013503","journal-title":"Virchows Arch"},{"issue":"4","key":"4341_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1023\/A:1007107110222","volume":"31","author":"I Ozbey","year":"1999","unstructured":"Ozbey I et al (1999) Squamous metaplasia of the bladder: findings in 14 patients and review of the literature. Int Urol Nephrol 31(4):457\u2013461","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"4341_CR16","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0302-2838(02)00358-5","volume":"42","author":"MS Khan","year":"2002","unstructured":"Khan MS et al (2002) Keratinising squamous metaplasia of the bladder: natural history and rationalization of management based on review of 54 years experience. Eur Urol 42(5):469\u2013474","journal-title":"Eur Urol"},{"issue":"3","key":"4341_CR17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0014-2964(79)90039-2","volume":"15","author":"MM El-Merzabani","year":"1979","unstructured":"El-Merzabani MM, El-Aaser AA, Zakhary NI (1979) A study on the aetiological factors of bilharzial bladder cancer in Egypt\u20131. Nitrosamines and their precursors in urine. Eur J Cancer 15(3):287\u2013291","journal-title":"Eur J Cancer"},{"issue":"1","key":"4341_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0022-5347(17)57035-4","volume":"120","author":"JL Radomski","year":"1978","unstructured":"Radomski JL et al (1978) Nitrosamine formation in bladder infections and its role in the etiology of bladder cancer. J Urol 120(1):48\u201350","journal-title":"J Urol"},{"issue":"1","key":"4341_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1750-9378-7-19","volume":"7","author":"H El-Mosalamy","year":"2012","unstructured":"El-Mosalamy H et al (2012) Role of chronic E. coli infection in the process of bladder cancer- an experimental study. Infect Agent Cancer 7(1):19","journal-title":"Infect Agent Cancer"},{"issue":"1","key":"4341_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/BLC-160068","volume":"3","author":"RS Matulewicz","year":"2017","unstructured":"Matulewicz RS et al (2017) Dipstick urinalysis as a test for microhematuria and occult bladder cancer. Bladder Cancer 3(1):45\u201349","journal-title":"Bladder Cancer"},{"issue":"5","key":"4341_CR21","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.juro.2010.12.093","volume":"185","author":"H Jung","year":"2011","unstructured":"Jung H et al (2011) Association of hematuria on microscopic urinalysis and risk of urinary tract cancer. J Urol 185(5):1698\u20131703","journal-title":"J Urol"},{"key":"4341_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1200\/EDBK_175558","volume":"37","author":"JB Aragon-Ching","year":"2017","unstructured":"Aragon-Ching JB, Pagliaro LC (2017) New developments and challenges in rare genitourinary tumors: non-urothelial bladder cancers and squamous cell cancers of the penis. Am Soc Clin Oncol Educ Book 37:330\u2013336","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"5","key":"4341_CR23","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1464-410X.1982.tb13580.x","volume":"54","author":"JS Rundle","year":"1982","unstructured":"Rundle JS et al (1982) Squamous cell carcinoma of bladder. a review of 114 patients. Br J Urol 54(5):522\u2013526","journal-title":"Br J Urol"},{"issue":"1","key":"4341_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0022-5347(17)39857-9","volume":"143","author":"DA Swanson","year":"1990","unstructured":"Swanson DA, Liles A, Zagars GK (1990) Preoperative irradiation and radical cystectomy for stages T2 and T3 squamous cell carcinoma of the bladder. J Urol 143(1):37\u201340","journal-title":"J Urol"},{"issue":"6","key":"4341_CR25","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/0090-4295(83)90303-5","volume":"22","author":"SI Tannenbaum","year":"1983","unstructured":"Tannenbaum SI et al (1983) Squamous carcinoma of urinary bladder. Urology 22(6):597\u2013599","journal-title":"Urology"},{"issue":"4","key":"4341_CR26","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.urology.2008.11.042","volume":"73","author":"E Scosyrev","year":"2009","unstructured":"Scosyrev E, Yao J, Messing E (2009) Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment? Urology 73(4):822\u2013827","journal-title":"Urology"},{"issue":"16","key":"4341_CR27","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMoa1106106","volume":"366","author":"ND James","year":"2012","unstructured":"James ND et al (2012) Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med 366(16):1477\u20131488","journal-title":"N Engl J Med"},{"issue":"1","key":"4341_CR28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/10668969211027264","volume":"30","author":"JB Gordetsky","year":"2022","unstructured":"Gordetsky JB et al (2022) The significance of squamous histology on clinical outcomes and PD-L1 expression in bladder cancer. Int J Surg Pathol 30(1):6\u201314","journal-title":"Int J Surg Pathol"},{"issue":"1","key":"4341_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000020105","volume":"37","author":"V Serretta","year":"2000","unstructured":"Serretta V et al (2000) Pure squamous cell carcinoma of the bladder in western countries. Report on 19 consecutive cases. Eur Urol 37(1):85\u201389","journal-title":"Eur Urol"},{"issue":"2","key":"4341_CR30","doi-asserted-by":"publisher","first-page":"e437","DOI":"10.1016\/j.clgc.2017.10.005","volume":"16","author":"H Zahoor","year":"2018","unstructured":"Zahoor H et al (2018) Patient characteristics, treatment patterns and prognostic factors in squamous cell bladder cancer. Clin Genitourin Cancer 16(2):e437\u2013e442","journal-title":"Clin Genitourin Cancer"},{"issue":"9","key":"4341_CR31","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1200\/JCO.2001.19.9.2527","volume":"19","author":"M Hussain","year":"2001","unstructured":"Hussain M et al (2001) Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer. J Clin Oncol 19(9):2527\u20132533","journal-title":"J Clin Oncol"},{"issue":"8","key":"4341_CR32","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1002\/1097-0142(19910415)67:8<2165::AID-CNCR2820670827>3.0.CO;2-M","volume":"67","author":"DJ Grignon","year":"1991","unstructured":"Grignon DJ et al (1991) Primary adenocarcinoma of the urinary bladder. a clinicopathologic analysis of 72 cases. Cancer 67(8):2165\u20132172","journal-title":"Cancer"},{"issue":"1","key":"4341_CR33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/0090-4295(93)90239-7","volume":"41","author":"L Fiter","year":"1993","unstructured":"Fiter L et al (1993) Signet-ring cell adenocarcinoma of bladder. Urology 41(1):30\u201333","journal-title":"Urology"},{"issue":"4","key":"4341_CR34","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/cncr.22060","volume":"107","author":"RA Ashley","year":"2006","unstructured":"Ashley RA et al (2006) Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer 107(4):712\u2013720","journal-title":"Cancer"},{"issue":"2","key":"4341_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.urology.2006.10.029","volume":"69","author":"MD Galsky","year":"2007","unstructured":"Galsky MD et al (2007) Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract. Urology 69(2):255\u2013259","journal-title":"Urology"},{"issue":"2","key":"4341_CR36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s12032-008-9106-7","volume":"26","author":"JY Hong","year":"2009","unstructured":"Hong JY et al (2009) Palliative chemotherapy for non-transitional cell carcinomas of the urothelial tract. Med Oncol 26(2):186\u2013192","journal-title":"Med Oncol"},{"issue":"6","key":"4341_CR37","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1016\/j.juro.2008.08.075","volume":"180","author":"DC Smith","year":"2008","unstructured":"Smith DC et al (2008) Phase II trial of paclitaxel, carboplatin and gemcitabine in patients with locally advanced carcinoma of the bladder. J Urol 180(6):2384\u20132388","journal-title":"J Urol"},{"issue":"24","key":"4341_CR38","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","volume":"28","author":"LC Pagliaro","year":"2010","unstructured":"Pagliaro LC et al (2010) Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol 28(24):3851\u20133857","journal-title":"J Clin Oncol"},{"issue":"6","key":"4341_CR39","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1159\/000362400","volume":"59","author":"Y Yanagihara","year":"2013","unstructured":"Yanagihara Y et al (2013) Modified FOLFOX6 chemotherapy in patients with metastatic urachal cancer. Chemotherapy 59(6):402\u2013406","journal-title":"Chemotherapy"},{"issue":"1","key":"4341_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1200\/JCO.2004.09.046","volume":"22","author":"RM Goldberg","year":"2004","unstructured":"Goldberg RM et al (2004) A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22(1):23\u201330","journal-title":"J Clin Oncol"},{"key":"4341_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.humpath.2018.05.005","volume":"79","author":"G Wang","year":"2018","unstructured":"Wang G et al (2018) Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases. Hum Pathol 79:57\u201365","journal-title":"Hum Pathol"},{"issue":"6","key":"4341_CR42","doi-asserted-by":"publisher","first-page":"353 e17","DOI":"10.1016\/j.urolonc.2019.01.020","volume":"37","author":"JT Matulay","year":"2019","unstructured":"Matulay JT et al (2019) The impact of squamous histology on survival in patients with muscle-invasive bladder cancer. Urol Oncol 37(6):353 e17-353 e24","journal-title":"Urol Oncol"},{"issue":"7","key":"4341_CR43","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00345-016-1962-8","volume":"35","author":"W Sui","year":"2017","unstructured":"Sui W et al (2017) Contemporary treatment patterns and outcomes of sarcomatoid bladder cancer. World J Urol 35(7):1055\u20131061","journal-title":"World J Urol"},{"issue":"1","key":"4341_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3233\/BLC-190258","volume":"6","author":"LN Diamantopoulos","year":"2020","unstructured":"Diamantopoulos LN et al (2020) Plasmacytoid urothelial carcinoma: response to chemotherapy and oncologic outcomes. Bladder Cancer 6(1):71\u201381","journal-title":"Bladder Cancer"},{"issue":"11","key":"4341_CR45","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nrurol.2017.125","volume":"14","author":"M Moschini","year":"2017","unstructured":"Moschini M et al (2017) Characteristics and clinical significance of histological variants of bladder cancer. Nat Rev Urol 14(11):651\u2013668","journal-title":"Nat Rev Urol"},{"issue":"10","key":"4341_CR46","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa2312117","volume":"390","author":"T Powles","year":"2024","unstructured":"Powles T et al (2024) Enfortumab vedotin and pembrolizumab in untreated advanced urothelial cancer. N Engl J Med 390(10):875\u2013888","journal-title":"N Engl J Med"},{"issue":"4","key":"4341_CR47","doi-asserted-by":"publisher","first-page":"e603","DOI":"10.1016\/j.clgc.2016.12.006","volume":"15","author":"M Moschini","year":"2017","unstructured":"Moschini M et al (2017) Pure but not mixed histologic variants are associated with poor survival at radical cystectomy in bladder cancer patients. Clin Genitourin Cancer 15(4):e603\u2013e607","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"4341_CR48","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00345-012-0976-0","volume":"30","author":"JK Wang","year":"2012","unstructured":"Wang JK et al (2012) Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis. World J Urol 30(6):801\u2013806","journal-title":"World J Urol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-04341-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-024-04341-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-04341-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T03:35:41Z","timestamp":1751600141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-024-04341-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["4341"],"URL":"https:\/\/doi.org\/10.1007\/s11255-024-04341-w","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ankara Bilkent City Hospital Ethical Commitee approved the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}